Responsive image

Common name


4-(3-pyridyl)pyrimidine

IUPAC name


4-(3-pyridyl)pyrimidine

SMILES


n1cnccc1c2cnccc2

Common name


4-(3-pyridyl)pyrimidine

IUPAC name


4-(3-pyridyl)pyrimidine

SMILES


n1cnccc1c2cnccc2

INCHI


InChI=1S/C9H7N3/c1-2-8(6-10-4-1)9-3-5-11-7-12-9/h1-7H

FORMULA


C9H7N3

Responsive image

Common name


4-(3-pyridyl)pyrimidine

IUPAC name


4-(3-pyridyl)pyrimidine





Molecular weight


157.172

clogP


2.024

clogS


-2.724

Frequency


0.0007





HBond Acceptor


3

HBond Donor


0

Total Polar
Surface Area


38.67

Number of Rings


2

Rotatable Bond


1

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD00484 Imatinib Responsive image Antineoplastic Agents; Immunosuppressive Agents; Protein Kinase Inhibitors; Antineoplastic and Immunomodulating Agents; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; For the treatment of Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML), Ph+ acute lymphoblastic leukaemia, myelodysplastic/myeloproliferative diseases, aggressive systemic mastocytosis, hypereosinophilic syndrome and/or chronic eosinophilic leukemia (CEL), dermatofibrosarcoma protuberans, and malignant gastrointestinal stromal tumors (GIST).
FDBD01336 Nilotinib Responsive image Antineoplastic Agents; Immunosuppressive Agents; Protein Kinase Inhibitors; Antineoplastic and Immunomodulating Agents; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors; Combined Inhibitors of CYP3A4 and P-glycoprotein; For the potential treatment of various leukemias, including chronic myeloid leukemia (CML).
2 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
1iep_ligand_1_0.mol2 1iep 1 -7.31 c1(ccncn1)c1cccnc1 12
3gvu_ligand_1_0.mol2 3gvu 1 -7.31 c1(ccncn1)c1cccnc1 12
2hyy_ligand_1_0.mol2 2hyy 1 -7.29 c1cc(cnc1)c1ccncn1 12
1t46_ligand_1_0.mol2 1t46 1 -7.24 c1(ccncn1)c1cccnc1 12
4bkj_ligand_1_0.mol2 4bkj 1 -7.05 c1(ccncn1)c1cccnc1 12
3be2_ligand_1_9.mol2 3be2 1 -6.91 c1(ccncn1)c1cnccc1 12
3gp0_ligand_1_6.mol2 3gp0 1 -6.91 c1nccc(n1)c1cccnc1 12
2oiq_ligand_1_0.mol2 2oiq 1 -6.90 c1(ccncn1)c1cccnc1 12
100 , 11